PQBSEVBOSMFHHZ-UNUAMGMHSA-N
Compound with spectra: 1 NMR
| SpectraBase Compound ID | GLqOhU7NSQa |
|---|---|
| InChI | InChI=1S/C16H26O5/c1-8-5-6-12-9(2)15(19-4)21-16(12)13(8)7-11(10(3)17)14(18)20-16/h8-9,11-15,18H,5-7H2,1-4H3/t8-,9-,11-,12+,13+,14-,15-,16-/m0/s1 |
| InChIKey | PQBSEVBOSMFHHZ-UNUAMGMHSA-N |
| Mol Weight | 298.38 g/mol |
| Molecular Formula | C16H26O5 |
| Exact Mass | 298.178024 g/mol |
| Enantiomer InChIKey | PQBSEVBOSMFHHZ-INWWWUPNSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | Unknown |
VFNWMYFAJSWIIU-IPMVXICZSA-N
(3R,3aS,6R,6aS,10S,10aS)-10-hydroxy-3,6,9-trimethyl-3,3a,4,5,6,6a,7,10-octahydrobenzo[h]benzofuran-2-one
1,5-Dimethyl-2,4,6,13-tetraoxapentacyclo[5.5.1.0(3,11).0(5,9).0(8,12)]tridecane
1,9-Di-n-butyl-3 beta,7 .alpha.-dimethoxy-2,8,12-trioxatetracyclo[7.2.1.0.(4,11)0.(6,10)]dodecane
5-(4-chlorophenyl)-N-{3-nitro-5-[3-(trifluoromethyl)phenoxy]phenyl}-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide
13-Methyl-8,10,12-Trioxapentacyclo[5.5.2.0(2,6).0(5,9)]-13-tetradecene
1,4-Dioxaspiro[4.4]nonane-6-carboxaldehyde, 6-methyl-7-(1,2,3,4-tetrahydro-6-methoxy-1-oxo-2-naphthalenyl)-, [6R-[6.alpha.,7.beta.(S*)]]-
2-(4-butoxyphenyl)-5-(4-tert-butylphenyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine
D-Mannose, 2-O-[2-(acetylamino)-2-deoxy-3,4,6-tris-O-(trimethylsilyl)-.beta.-D-glucopyranosyl]-3,4,5,6-tetrakis-O-(trimethylsilyl)-
10-BETA,11-BETA-EPOXY-GUAIANE-1-ALPHA,4-ALPHA-DIOL
| Title | Journal or Book | Year |
|---|---|---|
| Novel Rearrangement of the Trioxane Ring System of the Antimalarial Arteether upon Treatment with Acid in an Aqueous Methanol Solvent System | HETEROCYCLES | 1994 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.